Serious Adverse Events Among Older Patients in the ALTTO Trial Comparing Anti-HER2 w/ Lapatinib & Trastuzumab, Their sequence or Combination in the Adjuvant Treatment of HER2+ Early Breast Cancer
Comments 0
Login to view comments.
Click here to Login
